Mycobacterium tuberculosis glutamine synthetase (GS) is an essential enzyme involved in the pathogenicity of the organism. The screening of a compound library using a robust high-throughput screening (HTS) assay is currently thought to be the most efficient way of getting lead molecules, which are potent inhibitors for this enzyme. The authors have purified the enzyme to a >90% level from the recombinant Escherichia coli strain YMC21E, and it was used for partial characterization as well as standardization experiments. The results indicated that the K m of the enzyme for L-glutamine and hydroxylamine were 60 mM and 8.3 mM, respectively. The K m for ADP, arsenate, and Mn 2+ were 2 µM, 5 µM, and 25 µM, respectively. When the components were adjusted according to their K m values, the activity remained constant for at least 3 h at both 25°C and 37°C. The Z′ factor determined in microplate format indicated robustness of the assay. When the signal/noise ratios were determined for different assay volumes, it was observed that the 200-µl volume was found to be optimum. The DMSO tolerance of the enzyme was checked up to 10%, with minimal inhibition. The IC 50 value determined for L-methionine S-sulfoximine on the enzyme activity was 3 mM. Approximately 18,000 small molecules could be screened per day using this protocol by a Beckman Coulter HTS setup. (Journal of Biomolecular Screening 2005:725-729) 
INTRODUCTION

M
YCOBACTERIUM TUBERCULOSIS is the causative agent of tuberculosis (TB), a widespread disease that is responsible for 2 to 3 million deaths annually. 1, 2 About one-third of the world's population is infected with the bacterium with no signs of disease, and 10% of these infected individuals carry the latent form of the organism, which has the chance to get reactivated, causing these individuals to develop the disease during their lifetime. Furthermore, HIV infection has increased the risk of reactivation of Mycobacteria. 3 Currently, TB chemotherapy includes a long-term regimen of drug treatment for 6 to 9 months. Moreover, the antibiotics are not effective to the latent form of infection. Most alarmingly, most of the currently isolated pathogenic strains are resistant to the available drugs. 4 Thus, there is an urgent need for the discovery of new molecules with a novel mode of action. High-throughput screening (HTS) of libraries of chemically diverse compounds is thought to be one of the most efficient means of identifying novel molecules that inhibit a novel target. Few targets have been suggested in recent literature; an inhibitor could lead to the development of a novel drug against TB. 5, 6 Likewise, glutamine synthetase (GS) has been suggested as one potentially important determinant of M. tuberculosis pathogenesis. [7] [8] [9] [10] Inhibition of extracellular enzyme activity in M. tuberculosis culture, in infected THP-1 cell as well as in in vivo condition of guinea pig model by the substrate analogues, showed the potential of GS as a drug target against TB.
11,12
The 3-dimensional structure of the enzyme has also been extensively studied. 13 Conventionally, GS activity is monitored by biosynthetic as well as transfer assays. 7, 14, 15 The present study evaluates the kinetic properties of M. tuberculosis GS in transfer assay as well as converts it to a robust high-throughput assay for screening of a large, chemically diverse library.
MATERIALS AND METHODS
Materials
All the chemicals were obtained from Sigma. Unosphere 6 column matrix was purchased from BioRad. Beckman Coulter platform integrated with Biomek 2000, ORCA Robot, Thermo Forma CO 2 incubator, Shaker and BMG Polar Star were used to conduct screening of in-house compounds obtained from natural product fractions using SEP BOX from Sepiatek, Germany.
Purification of GS.
The enzyme GS was purified to homogeneity by following a modified method published earlier. [11] [12] [13] Escherichia coli YMC21E culture was grown in LB medium until 1.2 OD at 600 nm. The fully-grown culture was centrifuged at 2000g for 10 min, and the pellet thus obtained was resuspended in 2 ml of buffer (containing 10 mM imidazole pH 7.0, 10 mM MnCl 2 , 5 mM PMSF, and 5 mM 2-mercaptoethanol) per gram of wet cell pellet. Then the cell suspension was subjected to lysis using a French press until the OD at 600 nm dropped to 90% of the initial value. It was then centrifuged at 10,860g for 30 min. The supernatant was treated with 10% streptomycin sulfate by 10% volume of the supernatant and kept for 15 min and then centrifuged at 10,860g for 20 min. The supernatant was treated with 1 M acetic acid to a pH 5.15 and kept for 15 min. Again, the same was centrifuged at 10,860g for 20 min. The supernatant thus obtained was treated with 100% saturated ammonium sulfate 30% by volume. The pH was adjusted to 4.4 by adding 1 M acetic acid and kept for 15 min. It was centrifuge at 10,860g for 20 min. The pellet was resuspended in 5 ml buffer containing 50 mM Hepes buffer pH 7.2, 10 mM MnCl 2 , and 0.1 M NaCl centrifuged and dialyzed extensively against the same buffer. The dialyzed was centrifuged as mentioned earlier. The supernatant was subjected to ion exchange chromatography by using a Unosphere 6 column. The protein was loaded in the column equilibrated with a buffer consisting of 10 mM imidazole, 10 mM MnCl 2 , and 100 mM NaCl. M. tuberculosis GS was eluted from the column after applying an isocratic condition with 1.0 M NaCl in the loading buffer. The protein was incubated for 1 min at 80°C. The whole preparation was centrifuged at 10,860g for 20 min to remove the precipitate. The supernatant obtained at this stage contains more than 90% pure M. tuberculosis GS. The characterization and standardization experiments were carried out using this enzyme preparation. When the preparation was run through a Sepharose HR 6 column, it eluted at 640 kd, indicating dodecamer composition of the protein. The N-terminal sequence of the eluted protein confirmed that it was a glnA1 gene product of M. tuberculosis (data not shown). The protein concentration was measured by the Lowry method. 16 Enzyme assays. A modified procedure was followed to carry out M. tuberculosis GS transfer assay as described earlier.
14,15 The reaction was started by adding 400 µM ADP in 2 ml of reaction mixture containing 20 mM imidazole buffer pH 7.0, 60 mM hydroxylamine-HCl pH 7.0, 3 mM MnCl 2 , 30 mM glutamine, and 20 mM arsenate with sufficient volume of enzyme. In this reaction, hydroxylamine and L-glutamine were used as substrates in the presence of ADP and arsenate and metal ion as cofactors to yield γ-glutamylhydroxamate and ammonia. During enzymatic reaction, an unstable intermediate called γ-glutamyl arsenate is formed. It was proposed that arsenate binds the same site as phosphate in the biosynthetic reaction and attacks glutamine through its oxygen to form the intermediate. Subsequently, hydroxylamine binds the ammonium site and attacks the intermediate already bound on the enzyme surface to release γ-glutamylhydroxamate and ammonia. 14, 17 The stop reagent, 0.5 ml, containing FeCl 3 (5%), TCA (24%), and HCl (0.6 N), was added to stop the reaction as well as to form the purplish complex between γ-glutamylhydroxamate and FeCl 3 in acidic condition. 18 This reaction is being carried out to detect the enzyme activity in crude cell lysate because of its very specific color development, which nullifies the potential of assay artifacts. Incubation of the reaction mixture without ADP served as a blank. The color was monitored at 540 nm in a Cary 50 Bio spectrophotometer.
K m values were determined using varied concentrations of Lglutamine (5-500 mM), hydroxylamine (0.8-200 mM), ADP (0.5-20 µM), MnCl 2 (2-320 µM), and Na 3 AsO 4 (1-50 µm), keeping other components at a constant level. A Hanes-Wolf plot was drawn from the data point to find out the K m values of the respective components.
The final assay mix contained 20 mM imidazole buffer pH 7.0, 300 mM L-glutamine, 20 µM ADP, 60 mM hydroxylamine pH 7.0, 50 µM Na 3 AsO 4 , and 250 µM MnCl 2 .
The reaction was started by adding ADP in the reaction mixture and was monitored at 540 nm after addition of stopping reagent. In the classical assay, water was added instead of ADP in the blank. To use the HTS platform more conveniently in the microplate format, EDTA was added in a whole-reaction mix, which serves as a blank. The microplate format assays were carried out using 200 µl reaction mix, and the plates were incubated for 3 h at 25°C followed by addition of 50 µl stopping reagent to develop color. After adding the stopping reagent, the reading was taken using a 520-nm filter in BMG polar star. To calculate the activity, the reading in the blank well (plus EDTA) was subtracted from the control well unless otherwise mentioned. The Z′ factor was determined by following a published procedure.
19 L-methionine S-sulfoximine, a known inhibitor of the enzyme, was used to further validate the assay. 7, 10, 12 The dose-response curve was plotted by using a varied concentration of the inhibitor ranging from 0.25 to 20 mM in the same assay mix.
Adoption of the protocol to the Beckman Coulter HTS system was done using SAMI software. The program includes the following steps: 1) transfer a set of 3 assay plates containing 5 µl of compound solution of 1.25 mg/ml concentrations from Carousal to Biomek 2000, 2) add 175 µl of reaction mix to all wells, 3) start the reaction by adding 20 µl of ADP, 4) move plates to shaker for 30 s, 5) move the plates to the carousal again for a 3-h incubation at room temperature, 6) move the plates to Biomek 2000 for addition of 50 µl of stopping reagent, 7) move the plates to the BMG Polar Star for reading, and 8) return the plates to Carousal. The program takes 3 h, 33 min, to complete a screening of 12 plates and 5 h, 52 min, for 60 plates.
RESULTS
The purification profile of M. tuberculosis GS in E. coli strain YMC21E was evidenced from the SDS-PAGE analysis (Fig. 1) . This preparation was used for the determination of K m of all the substrates and cofactors required in the transfer assay. Hanes-Wolf plots were drawn to find out the K m values of all the constituents of assay mixture (Table 1 ). All the components were added at the saturating level with respect to their K m values to get linearity in activity for a longer period of incubation as well as insensitizing the protocol for competitive inhibitors to be picked up during screening. 
Validation
Linearity of the assay, effect of DMSO, and the inhibition of enzyme activity were monitored to validate the HTS format in a 96-well plate. The activity was monitored for 3 h at 37°C and 25°C, respectively, to check the linearity of assay (Fig. 2) . The results indicated that the enzyme activity was found to be linear at least for 3 h at both the temperatures. When the incubation was extended to 5 h at 25°C, the linearity was still maintained (data not shown). Similar results were obtained when experiments were carried out without shaking (data not shown).
To assess the robustness of the assay protocol in microplate format, the Z′ factor as well as signal/noise (S/N) ratio were determined with varying assay volumes and enzyme concentrations ( Table 2 ). It was observed that both the Z′ values as well as the S/N ratio improves with an increase in assay volumes. 19 As 0.5 µg/ml protein in 200 µl was showing the best result, the same was used to carry out subsequent assays. It was noted that the color developed in the final assay mix was stable up to 150 min (data not shown).
The effect of DMSO was checked to decide the volume of compound solution to be used for screening. The results showed that the enzyme activity was not changed significantly even at 10% DMSO concentration (Fig. 3) . Mixing of reagents for 30 s on a shaker is required to obtain uniformity in readings (data not shown).
The dose-response effect of L-methionine S-sulfoximine was checked to determine the IC 50 value in the standardized protocol (Fig. 4) . The IC 50 value obtained was 3 mM using a modified protocol. The plate assay also showed an almost similar result as the tube assay, indicative of true adoption of the assay in plate format. When the assay protocol was run on the Beckman Coultier HTS system, it was found that the system would take 3 h, 33 min, for 12 plates. The utilization time for 60 plates using the same program . In the inset are shown the representative Hanes-Wolf plots drawn using the data obtained from the above-mentioned protocol with varied hydroxylamine (plot I) and L-glutamine (plot II).
FIG. 1. SDS-PAGE of
Mycobacterium tuberculosis glutamine synthetase (GS) at different stages of purification. Equivalent amount of proteins were loaded in lanes as follows: 1) crude extract, 2) AS cut, 3) ion exchange chromatography, 4) after heating at 80°C and 5) 6 L marker proteins as described in the Materials and Methods section. 
FIG. 2. Time curve of
Mycobacterium tuberculosis glutamine synthetase (GS) activity 1) at 37°C and 2) at 25°C. The reaction was carried out with 0.5 µg/ml of M. tuberculosis GS in a reaction mixture containing 300 mM L-glutamine, 60 mM hydroxylamine pH 7.0, 20 µM ADP, 50 µM sodium arsenate, and 250 µM MnCl 2 at pH 7.0 at temperatures of 37°C (▲) and 25°C (■). The experiment was carried out in a final volume of 200 µl in a 96-well microplate as described in the Materials and Methods section. For each, a blank without ADP was carried out simultaneously. The result is the average of 3 identical experiments.
would take 5 h, 52 min, as indicated by SAMI software (data not shown).
DISCUSSION
A colorimetric assay for HTS is advantageous if the development of color takes place instantaneously and remains stable for a substantial period of time. Among the transfer and biosynthetic reactions of GS, the former was selected for further study for the development of assay format to HTS due to the fast and stable color formation of the assay mixture, which brings flexibility and convenience in screening programs. In addition to GS's playing a major role in M. tuberculosis pathogenicity, this enzyme is also found to be associated with certain human brain disorders. 20, 21 Considering the possibility of GS's becoming a target in the future and developing new molecules against those diseases, we attempted to provide a screening solution. A simple assay in a 96-well format for HTS of M. tuberculosis GS was developed by modifying a classical assay used earlier to check the enzyme activity in crude cell extract. 14 The developed assay is robust and meets all the stringent HTS criteria. The HTS criteria considered here are 1) linearity of enzyme activity for more than 3 h, 3) DMSO tolerance, 3) reproducible IC 50 value for the standard inhibitor, and 4) robustness of the assay protocol (Figs. 2-4 , Table 2 ). The results indicated that the Z′ factor alone is not sufficient for considering the robustness of the assay protocol; the S/N value is also very important. Therefore, along with the quality of the enzyme, optimum concentrations of the reagents and assay volume play important roles in obtaining a better S/N value. The high acidity of the stopping solution in this assay reduces the interference of colored compounds, except for a few, such as tannins. 22 The present assay was developed using purified recombinant GS, and the composition of the assay mix was optimized based on its K m values (Fig. 1, Table 1 ). The K m value for L-glutamine of the E. coli enzymes was also determined and found that it is giving almost the same value as mentioned earlier 14 (data not shown). This proves the authenticity of our K m data as well. An S/N ratio of~10 was obtained using these optimized assay conditions (Table 2) . A limited attempt was made earlier to determine the better inhibitor against this enzyme from structural analogues of L-glutamine. 18 Because of the allosteric nature of M. tuberculosis GS, apart from the picking up of competitive inhibitors, there are possibilities to pick up compounds with uncompetitive, noncompetitive, and The reaction was carried out with the indicated amount of protein in a reaction mixture containing 20 mM imidazole pH 7.0, 300 mM L-glutamine, 60 mM hydroxylamine pH 7.0, 20 µM ADP, 50 µM sodium arsenate, and 250 µM MnCl 2 at 25°C in a 96-well plate for 3 h. The rest are described in the Materials and Methods section. The result is an average of 3 identical experiments. allosteric inhibitors of the enzyme using this high-throughput assay and diverse chemical library. We have successfully screened 617 natural product fractions, 20 synthetic compounds, and 7 standard antibiotics including rifampicin. The results did not show any plate or distribution effect (data not shown). Further screening is presently under way in our laboratory.
